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Abstract—Identification of non-coding RNAs (ncRNAs) has
been significantly enhanced due to the rapid advancement in
sequencing technologies. On the other hand, semantic annotation
of ncRNA data lag behind their identification, and there is a great
need to effectively integrate discovery from relevant communities.
To this end, the Non-Coding RNA Ontology (NCRO) is being
developed to provide a precisely defined ncRNA controlled
vocabulary, which can fill a specific and highly needed niche
in unification of ncRNA biology.
Keywords—non-coding RNA, biological and biomedical on-
tologies, domain ontology, ontology development, semantic data
annotation and integration.
I. INTRODUCTION
Non-coding RNAs (ncRNAs) are special functional RNA
molecules that are not translated into protein, including transfer
RNAs (tRNAs), ribosomal RNAs (rRNAs), long ncRNAs
(lncRNAs), and microRNAs (miRNAs), etc. Research inter-
est in ncRNA biology has significantly grown, and a large
amount of information has been continuously obtained thanks
to rapidly developed sequencing technologies in recent years.
Unfortunately, semantic annotation and integration of data
about ncRNAs lag behind identification of ncRNAs; therefore,
effective methodologies are needed to bring together discovery
made by the ncRNA research community.
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Emerging semantic technologies have been successfully
applied to promote more precise communication among sci-
entists in biological, biomedical, and clinical domains [1–6].
In particular, the Open Biological and Biomedical Ontologies
(OBO) Library [7] has served as an umbrella for different bio-
ontologies shared across various domains. However, the OBO
Library does not include comprehensive ontologies targeted for
the ncRNA domain. Likewise, no such ncRNA ontologies are
found in the National Center for Biomedical Ontology (NCBO)
BioPortal [8] either.
The Non-Coding RNA Ontology (NCRO), to be described
in this paper, is the very first comprehensive domain ontology
specifically designed for the ncRNA field. The controlled
vocabulary that is precisely defined in the NCRO can be
utilized as a resource to annotate and integrate ncRNA data
generated by relevant communities. In the sense of semantic
data annotation and integration, the NCRO is meant to fill a
specific and highly needed niche in comprehensive unification
of ncRNA biology.
The rest of this paper is organized as follows. Section II
briefly summarizes state-of-the-art research work in both
ncRNA biology and bio-ontologies; Section III introduces
design principles, languages, and tools for the NCRO ontology
development; Section IV describes greater details of NCRO
terms and relations; and finally, Section V concludes with
future research directions.
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TABLE I. A SUBSET OF TERMS IN THE NCRO
Term Explanation
IRES A sequence element that recruits a ribosomal subunit to internal mRNA for translation initiation.
lncRNA An non-protein coding transcript (longer than 200 nt).
miRNA A small (22nt) RNA molecule that is the endogenous transcript of a miRNA gene.
promoter of miRNA The promoter to start the miRNA transcription.
riboswitch Part of mRNA, acting as a direct sensor of small molecules to control their own expression.
ribozyme An RNA molecule with catalytic activity.
rRNA Part of ribosome, providing structural scaffolding and catalytic activity.
snRNA A small nuclear RNA that is involved in pre-mRNA splicing and processing.
sRNA A small ncRNA molecule of 50-250 nt.
transcription of miRNA The transcription process of a miRNA.
II. RELATED WORK
A. Research in ncRNA biology
Abnormal expression of ncRNAs is involved in many hu-
man diseases [9] [10]. When differentially expressed ncRNAs
play regulatory roles in altering target gene expression, further
phenotypic effects can be realized. Differential expression of
ncRNAs in malignant tissues compared with normal tissues
can be exploited as potential therapeutic targets for cancer
therapy or as biomarkers used for diagnosis, prediction of
patient outcome, or monitoring the effectiveness of cancer
therapeutics [11]. In recent years serious attempts have been
made to effectively deliver ncRNA into tumors in animal
models [12–14].
B. Research in bio-ontologies
RNA Ontology (RNAO) [15]: RNAO is an OBO foundry
reference ontology to catalogue the molecular entities compos-
ing primary, secondary, and tertiary components of RNA. The
goal of the RNAO project is to enable integration and analysis
of diverse RNA datasets.
Gene Ontology (GO) [16]: GO is by far the most successful
and widely used bio-ontology, consisting of three independent
sub-ontologies: biological processes, molecular functions, and
cellular components. The GO has been utilized to annotate
gene products of model organisms including Homo sapiens.
Ontology for microRNA Target (OMIT): OMIT [17] [18]
is a miRNA domain ontology being developed as part of the
NIH OmniSearch project. The purpose is to establish standard
metadata in miRNA domain for more effective identification
of miRNAs’ roles in various human diseases.
Sequence Ontology (SO) [19]: SO is an ontology to capture
genomic features and the relationships that obtain between
them. This ontology contains the features necessary to annotate
a genome with structural features such as gene models and also
the terms necessary for the annotation of genomic variants.
PRotein Ontology (PRO) [20]: Proteins are functional en-
tities in many processes eventually impacted by the regulatory
effect of ncRNAs (e.g., miRNA bindings). The PRO, with a
particular focus on human proteins and disease-related variants
thereof, provides an ontological representation of proteins.
III. THE DEVELOPMENT OF THE NCRO
A. Development principles
In the development pipeline for the NCRO, we have
observed a set of practices proposed by the OBO Foundry
Initiative [21] [22]. For example, the ontology should be: freely
available; expressed in a standard language; documented for
successive versions; orthogonal to existing ontologies; includ-
ing natural language specifications; developed collaboratively;
and used by multiple researchers.
B. BFO-compliant ontology
All NCRO terms descend from terms defined in the Basic
Formal Ontology (BFO) [23]. The BFO is a small, upper-
level ontology that is designed for use in supporting infor-
mation retrieval, analysis, and integration in scientific and
other domains. Because the BFO is a well-established upper
ontology adopted by all OBO ontologies, our strategy to make
the NCRO a BFO-compliant ontology will set the stage for
interoperability between the NCRO and other OBO ontologies.
C. Ontology languages and development tools
Both the OBO and Web Ontology Language (OWL) [24]
formats have been chosen to describe the ontology. We used
OBO-Edit [25] to generate an OBO version of the ontology
file in the first place; we then utilized the obo-release-manager
(OORT) tool [26] to convert the ontology file into an equivalent
OWL version; finally we verified the converted ontology in
Prote´ge´ [27].
IV. NCRO TERMS AND RELATIONS
While greater details of all terms and relations in the
NCRO are publicly available [28] [29], the ontology design
is exhibited as follows.
• Table I presents a subset of representative terms de-
fined in the NCRO.
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Fig. 1. Core terms and relations in the NCRO ontology.
Fig. 2. The NCRO ontology in the OBO-Edit GUI.
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• Fig. 1 demonstrates a collection of core terms and
relations in the NCRO.
• Fig. 2 is a screenshot of the NCRO ontology in the
OBO-Edit graphic user interface (GUI).
V. CONCLUSIONS
Research interest in ncRNA biology has significantly
grown in recent years, resulting in a great need to estab-
lish common data elements and data exchange standards for
relevant communities to share their discovery. Neither the
OBO Library nor the NCBO BioPort contains ontologies
that are specifically designed for the ncRNA domain. It thus
motivated us to develop the NCRO ontology to fill such an
important knowledge gap. The NCRO aims to provide a set
of standardized terms and relations to facilitate semantics-
oriented knowledge capture out of large amounts of ncRNA
data that are continuously generated from ncRNA and related
communities.
The NCRO is an on-going research effort, and ontology
files and design documentations are publicly available on a
designated project website housed in the University of South
Alabama domain [28], as well as on the GitHub project site
[29]. In addition, the NCRO ontology is also included in both
the OBO Library [30] and the NCBO BioPortal [31].
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